Phase I Study of Valproic Acid Given in Combination With Bevacizumab in Patients With Advanced Cancer to Determine Safety and Tolerability.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Bevacizumab (Primary) ; Valproic acid
- Indications Cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 30 Nov 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 16 Nov 2013 Status changed from active, no longer recruiting to discontinued as reported by M.D. Anderson Cancer Center